187 related articles for article (PubMed ID: 33416466)
1. Inhibition of canine distemper virus replication by blocking pyrimidine nucleotide synthesis with A77 1726, the active metabolite of the anti-inflammatory drug leflunomide.
Li Y; Yi L; Cheng S; Wang Y; Wang J; Sun J; Zhang Q; Xu X
J Gen Virol; 2021 Mar; 102(3):. PubMed ID: 33416466
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of p70 S6 kinase (S6K1) activity by A77 1726 and its effect on cell proliferation and cell cycle progress.
Doscas ME; Williamson AJ; Usha L; Bogachkov Y; Rao GS; Xiao F; Wang Y; Ruby C; Kaufman H; Zhou J; Williams JW; Li Y; Xu X
Neoplasia; 2014 Oct; 16(10):824-34. PubMed ID: 25379019
[TBL] [Abstract][Full Text] [Related]
3. A77 1726, the active metabolite of the anti-rheumatoid arthritis drug leflunomide, inhibits influenza A virus replication in vitro and in vivo by inhibiting the activity of Janus kinases.
Wang J; Sun J; Hu J; Wang C; Prinz RA; Peng D; Liu X; Xu X
FASEB J; 2020 Aug; 34(8):10132-10145. PubMed ID: 32598086
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of porcine epidemic diarrhea virus (PEDV) replication by A77 1726 through targeting JAK and Src tyrosine kinases.
Li X; Sun J; Prinz RA; Liu X; Xu X
Virology; 2020 Dec; 551():75-83. PubMed ID: 32829915
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of p70 S6 kinase activity by A77 1726 induces autophagy and enhances the degradation of superoxide dismutase 1 (SOD1) protein aggregates.
Sun J; Mu Y; Jiang Y; Song R; Yi J; Zhou J; Sun J; Jiao X; Prinz RA; Li Y; Xu X
Cell Death Dis; 2018 Mar; 9(3):407. PubMed ID: 29540819
[TBL] [Abstract][Full Text] [Related]
6. Two activities of the immunosuppressive metabolite of leflunomide, A77 1726. Inhibition of pyrimidine nucleotide synthesis and protein tyrosine phosphorylation.
Xu X; Williams JW; Gong H; Finnegan A; Chong AS
Biochem Pharmacol; 1996 Aug; 52(4):527-34. PubMed ID: 8759024
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of p70 S6 kinase (S6K1) activity by A77 1726, the active metabolite of leflunomide, induces autophagy through TAK1-mediated AMPK and JNK activation.
Xu X; Sun J; Song R; Doscas ME; Williamson AJ; Zhou J; Sun J; Jiao X; Liu X; Li Y
Oncotarget; 2017 May; 8(18):30438-30454. PubMed ID: 28389629
[TBL] [Abstract][Full Text] [Related]
8. In vivo activity of leflunomide: pharmacokinetic analyses and mechanism of immunosuppression.
Chong AS; Huang W; Liu W; Luo J; Shen J; Xu W; Ma L; Blinder L; Xiao F; Xu X; Clardy C; Foster P; Williams JA
Transplantation; 1999 Jul; 68(1):100-9. PubMed ID: 10428276
[TBL] [Abstract][Full Text] [Related]
9. Control of hyperglycemia in male mice by leflunomide: mechanisms of action.
Chen J; Sun J; Doscas ME; Ye J; Williamson AJ; Li Y; Li Y; Prinz RA; Xu X
J Endocrinol; 2018 Apr; 237(1):43-58. PubMed ID: 29496905
[TBL] [Abstract][Full Text] [Related]
10. Restriction of intracellular Salmonella typhimurium growth by the small-molecule autophagy inducer A77 1726 through the activation of the AMPK-ULK1 axis.
Zhuang J; Ji X; Zhu Y; Liu W; Sun J; Jiao X; Xu X
Vet Microbiol; 2021 Mar; 254():108982. PubMed ID: 33461007
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of dihydroorotate dehydrogenase (DHODH) inhibitors "leflunomide" and "teriflunomide" in Covid-19: A narrative review.
Kaur H; Sarma P; Bhattacharyya A; Sharma S; Chhimpa N; Prajapat M; Prakash A; Kumar S; Singh A; Singh R; Avti P; Thota P; Medhi B
Eur J Pharmacol; 2021 Sep; 906():174233. PubMed ID: 34111397
[TBL] [Abstract][Full Text] [Related]
12. In vivo mechanism by which leflunomide controls lymphoproliferative and autoimmune disease in MRL/MpJ-lpr/lpr mice.
Xu X; Blinder L; Shen J; Gong H; Finnegan A; Williams JW; Chong AS
J Immunol; 1997 Jul; 159(1):167-74. PubMed ID: 9200452
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of the antiproliferative action of leflunomide. A77 1726, the active metabolite of leflunomide, does not block T-cell receptor-mediated signal transduction but its antiproliferative effects are antagonized by pyrimidine nucleosides.
Cao WW; Kao PN; Chao AC; Gardner P; Ng J; Morris RE
J Heart Lung Transplant; 1995; 14(6 Pt 1):1016-30. PubMed ID: 8719445
[TBL] [Abstract][Full Text] [Related]
14. Species-related inhibition of human and rat dihydroorotate dehydrogenase by immunosuppressive isoxazol and cinchoninic acid derivatives.
Knecht W; Löffler M
Biochem Pharmacol; 1998 Nov; 56(9):1259-64. PubMed ID: 9802339
[TBL] [Abstract][Full Text] [Related]
15. In Vitro and In Vivo Antiviral Activity of Gingerenone A on Influenza A Virus Is Mediated by Targeting Janus Kinase 2.
Wang J; Prinz RA; Liu X; Xu X
Viruses; 2020 Oct; 12(10):. PubMed ID: 33050000
[TBL] [Abstract][Full Text] [Related]
16. In vitro antiviral efficacy of caffeic acid against canine distemper virus.
Wu ZM; Yu ZJ; Cui ZQ; Peng LY; Li HR; Zhang CL; Shen HQ; Yi PF; Fu BD
Microb Pathog; 2017 Sep; 110():240-244. PubMed ID: 28687324
[TBL] [Abstract][Full Text] [Related]
17. Purification of human dihydro-orotate dehydrogenase and its inhibition by A77 1726, the active metabolite of leflunomide.
Bruneau JM; Yea CM; Spinella-Jaegle S; Fudali C; Woodward K; Robson PA; Sautès C; Westwood R; Kuo EA; Williamson RA; Ruuth E
Biochem J; 1998 Dec; 336 ( Pt 2)(Pt 2):299-303. PubMed ID: 9820804
[TBL] [Abstract][Full Text] [Related]
18. Canine distemper virus N protein induces autophagy to facilitate viral replication.
Chen F; Guo Z; Zhang R; Zhang Z; Hu B; Bai L; Zhao S; Wu Y; Zhang Z; Li Y
BMC Vet Res; 2023 Mar; 19(1):60. PubMed ID: 36922800
[TBL] [Abstract][Full Text] [Related]
19. Potent antiviral activity of brequinar against the emerging Cantagalo virus in cell culture.
Schnellrath LC; Damaso CR
Int J Antimicrob Agents; 2011 Nov; 38(5):435-41. PubMed ID: 21840180
[TBL] [Abstract][Full Text] [Related]
20. Leflunomide inhibits PDK1/Akt pathway and induces apoptosis of human mast cells.
Sawamukai N; Saito K; Yamaoka K; Nakayamada S; Ra C; Tanaka Y
J Immunol; 2007 Nov; 179(10):6479-84. PubMed ID: 17982036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
